Neonatal seizures therapy: we are still looking for the efficacious drug

Area of Science:

• Neonatal neurology
• Pharmacology
• Neurodevelopmental outcomes

Background:

• Neonatal seizures pose significant risks to neurodevelopmental outcomes.
• Existing therapeutic options for neonatal seizures demonstrate limited efficacy and carry risks of long-term neurotoxicity.
• A recent systematic review aimed to establish a treatment algorithm for neonatal seizures.

Discussion:

• The current treatment algorithm relies heavily on traditional antiepileptic drugs due to a scarcity of clinical studies.
• There is a lack of distinction between different neonatal populations, such as preterm and hypothermic neonates, in current treatment guidelines.
• A dedicated approach is necessary for specific neonatal populations to optimize seizure management and minimize adverse effects.

Key Insights:

• Neonatal seizure treatments require improvement in both efficacy and safety profiles.
• The current evidence base is insufficient to guide tailored treatment strategies for diverse neonatal populations.
• Specialized approaches are crucial for preterm and hypothermic neonates to enhance seizure control and mitigate neurotoxic risks.

Outlook:

• Future research should focus on developing novel therapeutic agents for neonatal seizures.
• Clinical trials are needed to investigate the efficacy and safety of different antiepileptic drugs in specific neonatal subgroups.
• Developing population-specific treatment algorithms is essential for improving long-term neurodevelopmental outcomes in infants experiencing seizures.